Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-14T23:21:22.017Z Has data issue: false hasContentIssue false

Cardiac disease in Kearns-Sayre syndrome requires comprehensive management

Published online by Cambridge University Press:  04 July 2019

Josef Finsterer*
Affiliation:
Krankenanstalt Rudolfstiftung, Messerli Institute, Vienna, Austria
*
Author for Correspondence: J. Finsterer, MD, PhD, Postfach 20, 1180 Vienna, Austria. Tel: +43-1-71165-72085; Fax: +43-1-71165; E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© Cambridge University Press 2019 

With interest we read the article by Trivedi et al about a 7-year-old female with multi-system Kearns-Sayre syndrome manifesting as developmental delay, hypotonia, failure to thrive, hypoparathyroidism with consecutive hypocalcemia, ptosis, and cardiac conduction defect.Reference Trivedi, Goldstein and Arora1 The patient received a prophylactic pacemaker in the absence of a complete atrioventricular block.Reference Trivedi, Goldstein and Arora1 We have the following comments and concerns.

We do not agree with the statement in the introduction that cardiac complications of Kearns-Sayre syndrome only include left anterior fascicular block, right bundle branch block, and complete atrioventricular block.Reference Trivedi, Goldstein and Arora1 Cardiac involvement in Kearns-Sayre syndrome is variable and may also include dilated cardiomyopathyReference Obara-Moszynska, Maceluch and Bobkowski2 requiring a ventricular assist device,Reference Sehgal, Choudhry, Debelenko and L’Ecuyer3 bradycardia-related polymorphic ventricular tachycardia,Reference Kabunga, Lau and Phan4 myocardial scarring,Reference Kabunga, Lau and Phan4 or ventricular arrhythmias, including QT-prolongation,Reference van Beynum, Morava and Taher5 ventricular tachycardia,Reference van Beynum, Morava and Taher5 or torsades des pointes.Reference van Beynum, Morava and Taher5, Reference Wilmin, De Bels, Knecht, Gottignies, Gazagnes and Devriendt6

We also do not agree with the management of the presented patient. Since patients with Kearns-Sayre syndrome not only develop atrioventricular block but also ventricular arrhythmiasReference van Beynum, Morava and Taher5 and experience sudden cardiac death,Reference Krishna7 we should be informed about the results of long-term electrocardiography recordings by means of a reveal recorder. Kearns-Sayre syndrome patients may not only require implantation of a pacemaker but rather implantation of a loop recorder or an implantable cardioverter defibrillator.Reference Al Ghamdi8 In a retrospective study of 35 patients with Kearns-Sayre syndrome, four (11%) died after diagnosis.Reference Khambatta, Nguyen, Beckman and Wittich9 Interestingly, all four patients of this study experienced sudden cardiac death.Reference Khambatta, Nguyen, Beckman and Wittich9 Thus, prophylactic implantation of an implantable cardioverter defibrillator rather than a pacemaker should be considered.

Recently, it has been shown that subclinical cardiac involvement may be detected by application of cardiac MRI, including late gadolinium enhancement.Reference Kabunga, Lau and Phan4 Thus, we should be informed about the findings on cardiac MRI in the presented patient.

Though Kearns-Sayre syndrome is due to sporadic, single mitochondrial deoxy-nucleic acid deletions in the majority of cases, there is a 4% risk of inheritance.Reference Poulton, Finsterer and Yu-Wai-Man10 Thus, we should be informed if Kearns-Sayre syndrome in the presented patient was inherited from her mother or sporadic, if the mother had clinical manifestations, or if she carried the mitochondrial deoxy-nucleic acid deletion as well.

Patients with Kearns-Sayre syndrome may not only present with developmental delay, hypotonia, failure to thrive, hypoparathyroidism, ptosis, or cardiac conduction defect, but also with dementia, dysarthria, dystonia, cataracts, pigmentary retinopathy, hypoacusis, diabetes, growth retardation, myopathy, or elevated cerebrospinal fluid protein.Reference Tzoufi, Makis and Chaliasos11, Reference Shemesh and Margolin12 Since these features may not be present at onset or during the first years but may develop during the further disease trajectory, long-term follow-up of these patients is required.

In summary, this interesting case report could be more meaningful by discussing the broad heterogeneity of cardiac disease in Kearns-Sayre syndrome, by genetic investigation of the mother, by investigating the index case with cardiac MRI, and by prospective investigations of the index case for multi-system involvement. Even if a pacemaker is implanted, we should watch out for ventricular arrhythmias, consider loop recording, and eventually implantation of an implantable cardioverter defibrillator.

Acknowledgements

None.

Conflicts of Interest

None.

Author Contribution

JF; design, literature search, discussion, and first draft.

References

Trivedi, M, Goldstein, A, Arora, G. Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome. Cardiol Young 2018; 28: 14871488. doi: 10.1017/S1047951118001609CrossRefGoogle ScholarPubMed
Obara-Moszynska, M, Maceluch, J, Bobkowski, W, et al. A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment. BMC Pediatr 2013; 13: 27. doi: 10.1186/1471-2431-13-27CrossRefGoogle Scholar
Sehgal, S, Choudhry, S, Debelenko, L, L’Ecuyer, T. Dilated cardiomyopathy with cardiogenic shock in a child with Kearns-Sayre syndrome. BMJ Case Rep 2016. pii: bcr2015213813. doi: 10.1136/bcr-2015-213813CrossRefGoogle Scholar
Kabunga, P, Lau, AK, Phan, K, et al. Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 2015; 181: 303310.CrossRefGoogle ScholarPubMed
van Beynum, I, Morava, E, Taher, M, et al. Cardiac arrest in Kearns-Sayre syndrome. JIMD Rep 2012; 2: 710.CrossRefGoogle ScholarPubMed
Wilmin, S, De Bels, D, Knecht, S, Gottignies, P, Gazagnes, MD, Devriendt, J. Torsade de pointes in Kearns-Sayre syndrome. Pract Neurol 2012; 12: 199201.CrossRefGoogle ScholarPubMed
Krishna, MR. Kearns Sayre Syndrome: looking beyond A-V conduction. Indian Pacing Electrophysiol J 2017; 17: 7880.CrossRefGoogle ScholarPubMed
Al Ghamdi, A. Anesthetic management of a parturient with Kearns-Sayre syndrome, dual-chamber and VVI implantable defibrillator pacemaker/defibrillator, and preeclampsia for cesarean delivery: a case report and review of the literature. Saudi J Anaesth 2018; 12: 134138.10.4103/sja.SJA_630_17CrossRefGoogle ScholarPubMed
Khambatta, S, Nguyen, DL, Beckman, TJ, Wittich, CM. Kearns-Sayre syndrome: a case series of 35 adults and children. Int J Gen Med 2014; 7: 325332.Google ScholarPubMed
Poulton, J, Finsterer, J, Yu-Wai-Man, P. Genetic counselling for maternally inherited mitochondrial disorders. Mol Diagn Ther 2017; 21: 419429.CrossRefGoogle ScholarPubMed
Tzoufi, M, Makis, A, Chaliasos, N, et al. A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 2013; 172: 557561.CrossRefGoogle Scholar
Shemesh, A, Margolin, E. Kearns Sayre Syndrome. 2018 Feb 21. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2018. Available from http://www.ncbi.nlm.nih.gov/books/NBK482341/Google Scholar